IPP Bureau

Digital Health: An opportunity to increase health equity
Digital Health: An opportunity to increase health equity

By IPP Bureau - April 14, 2023

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%

FDA accepts application for Merck’s Keytruda plus chemotherapy as first-line treatment for metastatic gastric
FDA accepts application for Merck’s Keytruda plus chemotherapy as first-line treatment for metastatic gastric

By IPP Bureau - April 14, 2023

Acceptance based on results from the Phase 3 KEYNOTE-859 trial, which showed significant overall survival benefit in these patients with HER2-negative disease, regardless of PD-L1 expression

Advanced library amplification mix delivers superior NGS data quality
Advanced library amplification mix delivers superior NGS data quality

By IPP Bureau - April 14, 2023

NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.

Over 60% of ambulances violates tyre safety requirements: Survey
Over 60% of ambulances violates tyre safety requirements: Survey

By IPP Bureau - April 14, 2023

The survey inspected ambulances operating throughout the city

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines
DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

By IPP Bureau - April 13, 2023

Science communication brings behavioural changes

India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh
India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh

By IPP Bureau - April 13, 2023

India's strategy against Covid was more effective than any other countries in the world

LifeSigns introduces ‘Continuum Care’ for Patients
LifeSigns introduces ‘Continuum Care’ for Patients

By IPP Bureau - April 13, 2023

Enabling wireless monitoring In ambulances and homes

ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients
ProBioGen and ImmunOs Therapeutics join hands to deliver innovative therapy for cancer patients

By IPP Bureau - April 13, 2023

ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.

AI-backed innovations to drive Australia ultrasound systems market, says GlobalData
AI-backed innovations to drive Australia ultrasound systems market, says GlobalData

By IPP Bureau - April 13, 2023

Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad
Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad

By IPP Bureau - April 12, 2023

The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament

Zydus receives final approval from USFDA for Tavaborole Topical Solution
Zydus receives final approval from USFDA for Tavaborole Topical Solution

By IPP Bureau - April 12, 2023

Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes

By IPP Bureau - April 12, 2023

Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes

CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells
CiRA, Kyoto University and Astellas Phase 2 research agreement signed for iPS Cells

By IPP Bureau - April 12, 2023

CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells

Zydus receives final approval from the USFDA for Azithromycin Tablets
Zydus receives final approval from the USFDA for Azithromycin Tablets

By IPP Bureau - April 11, 2023

Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States

Cipla signs agreement with Novartis for diabetes therapy Galvus range
Cipla signs agreement with Novartis for diabetes therapy Galvus range

By IPP Bureau - April 11, 2023

Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore

Latest Stories

Interviews

Packaging